Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma

Hanna Karvonen; Danilela Ungureanu; David Chiron; Wilhelmiina Niininen; Sara Ek; Mats Jerkeman; Elaheh Moradi; Matti Nykter; Caroline A Heckman; Astrid Murumägi

doi:10.1182/bloodadvances.2017010215

Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma

Hanna Karvonen, Danilela Ungureanu, David Chiron, Wilhelmiina Niininen, Sara Ek, Mats Jerkeman, Elaheh Moradi, Matti Nykter, Caroline A Heckman, Astrid Murumägi

Research output: Contribution to journal › Article › Scientific › peer-review

23 Citations (Scopus)

Original language	English
Pages (from-to)	2257-2268
Journal	Blood Advances
Volume	1
Issue number	24
DOIs	https://doi.org/10.1182/bloodadvances.2017010215
Publication status	Published - 2017
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 0

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1182/bloodadvances.2017010215

Cite this

@article{6d5542dc4e164fb48179bd6d7594bc86,

title = "Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma",

author = "Hanna Karvonen and Danilela Ungureanu and David Chiron and Wilhelmiina Niininen and Sara Ek and Mats Jerkeman and Elaheh Moradi and Matti Nykter and Heckman, {Caroline A} and Astrid Murum{\"a}gi",

year = "2017",

doi = "10.1182/bloodadvances.2017010215",

language = "English",

volume = "1",

pages = "2257--2268",

number = "24",

}

TY - JOUR

T1 - Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma

AU - Karvonen, Hanna

AU - Ungureanu, Danilela

AU - Chiron, David

AU - Niininen, Wilhelmiina

AU - Ek, Sara

AU - Jerkeman, Mats

AU - Moradi, Elaheh

AU - Nykter, Matti

AU - Heckman, Caroline A

AU - Murumägi, Astrid

PY - 2017

Y1 - 2017

U2 - 10.1182/bloodadvances.2017010215

DO - 10.1182/bloodadvances.2017010215

M3 - Article

SN - 2473-9537

VL - 1

SP - 2257

EP - 2268

JO - Blood Advances

JF - Blood Advances

IS - 24

ER -